BioDelivery Sciences International (FRA:BD5) Scaled Net Operating Assets : 0.54 (As of Dec. 2021)

View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BioDelivery Sciences International's operating assets for the quarter that ended in Dec. 2021 was €186.1 Mil. BioDelivery Sciences International's operating liabilities for the quarter that ended in Dec. 2021 was €69.0 Mil. BioDelivery Sciences International's Total Assets for the quarter that ended in Sep. 2021 was €217.7 Mil. Therefore, BioDelivery Sciences International's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2021 was 0.54.

BioDelivery Sciences International Scaled Net Operating Assets Historical Data

The historical data trend for BioDelivery Sciences International's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Scaled Net Operating Assets Chart

BioDelivery Sciences International Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.61

0.44

0.61

0.38

0.59

BioDelivery Sciences International Quarterly Data
	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.32	0.30	0.30	0.33	0.54

Competitive Comparison of BioDelivery Sciences International's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, BioDelivery Sciences International's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioDelivery Sciences International's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioDelivery Sciences International's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where BioDelivery Sciences International's Scaled Net Operating Assets falls into.

BioDelivery Sciences International Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BioDelivery Sciences International's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2021 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2021 )
=	(Operating Assets (A: Dec. 2021 )	-	Operating Liabilities (A: Dec. 2021 ))	/	Total Assets (A: Dec. 2020 )
=	(186.104	-	69.014)	/	197.193
=	0.59

where

	Operating Assets		(A: Dec. 2021 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	287.267	-	101.163
=	186.104

	Operating Liabilities		(A: Dec. 2021 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	121.045	-	47.947	-	4.084
=	69.014

BioDelivery Sciences International's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2021 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2021 )
=	(Operating Assets (Q: Dec. 2021 )	-	Operating Liabilities (Q: Dec. 2021 ))	/	Total Assets (Q: Sep. 2021 )
=	(186.104	-	69.014)	/	217.66
=	0.54

where

	Operating Assets		(Q: Dec. 2021 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	287.267	-	101.163
=	186.104

	Operating Liabilities		(Q: Dec. 2021 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	121.045	-	47.947	-	4.084
=	69.014

BioDelivery Sciences International Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

BioDelivery Sciences International (FRA:BD5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612

Website

http://www.bdsi.com

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines